Atrial natriuretic peptide inhibits the release of endothelium-derived relaxing factor from blood vessels of the rabbit
- 1 June 1989
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 165 (1) , 129-134
- https://doi.org/10.1016/0014-2999(89)90778-4
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Release of Endothelium-Derived Relaxing Factor is Inhibited by 8-Bromo-Cyclic Guanosine MonophosphateJournal of Cardiovascular Pharmacology, 1988
- In vivo EDRF activity influences platelet functionBritish Journal of Pharmacology, 1988
- Endothelium-derived relaxing factor (EDRF) and resistance vessels in an intact vascular bed: a microangiographic study of the rabbit isolated earBritish Journal of Pharmacology, 1988
- Endothelium‐derived relaxing factor and atriopeptin II elevate cyclic GMP levels in pig aortic endothelial cellsBritish Journal of Pharmacology, 1988
- Nitric oxide (NO) formation from nitrovasodilators occurs independently of hemoglobin or non-heme ironEuropean Journal of Pharmacology, 1987
- Endothelium‐derived relaxing factor inhibits in vitro platelet aggregationBritish Journal of Pharmacology, 1987
- Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factorNature, 1986
- Comparison of binding and cyclic GMP accumulation by atrial natriuretic peptides in endothelial cellsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1986
- Regional vasorelaxant selectivity of atrial natriuretic factor in isolated rabbit vesselsLife Sciences, 1985
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980